News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Stephanie Saw: Intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status
Stephanie Saw/X
Mar 5, 2025, 12:30

Stephanie Saw: Intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status

Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a paper she and her colleagues authored on X:

“Pleased to share our work examining intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status and agreement between assays in Lung Cancer Journal. My first IASLC young investigator grant and Conquer Cancer Foundation merit award! Thanks to all co-authors.”

EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer

Authors: Stephanie Saw et al.

Stephanie Saw

Aaron C. Tan Amit Jain Angela Takano Anne James Boon-Hean Ong cancer Craig Joseph Daniel S. W. Tan Darren W.T. Lim Gillianne G.Y. Lai Joe P.S. Yeong Mei-Kim Ang Nwe Oo Hlaing OncoDaily Oncology Quan Sing Ng Ravindran Kanesvaran Siqin Zhou Stephanie P.L. Saw Sze Huey Tan Tony K.H. Lim Wan Ling Tan Yi Lin Teh
Special Coverage
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma
Blog
Apr 4, 2025, 19:34
Matthew Kurian: The barriers to AI adoption in oncology
Blog
Apr 4, 2025, 19:19
Michaela Cada: Proud to be part of the SickKids family for 20 years
Blog
Apr 4, 2025, 19:05
Laurence Albiges: Day 1 of ESMO Preceptorship in metastatic urothelial RCC cancer
Blog
Apr 4, 2025, 18:55
The invisible killer in your lungs - Pink Hearts Cancer Support Foundation
Blog
Apr 4, 2025, 18:54
Yelak Biru: How pharma medical affairs and innovation teams can learn from Myelo’s AI journey
Insight
Apr 4, 2025, 18:36
Luis Lara-Mejía: Neoadjuvant aumolertinib converted 45.1% of unresectable stage III EGFRm NSCLC to resectable status
Insight
Apr 4, 2025, 18:06
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Blog
Apr 4, 2025, 17:45
Raj Batra: The absence of scientific rationale underlying contemporary clinical trials in lung cancers